TNFRSF11B and inflammatory bowel disease: This stronger response was not limited to the OPG, because we found multiple serum biomarkers (e.g., MMP-14, MBL, CD14, I-FABP, L-FABP, ROBO4) increased in patients with PSC-IBD.